Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan

Characterization of Anti-Emicizumab Antibodies Using Repository Samples Obtained in Clinical Studies of Emicizumab Conducted in Japan

Bibliographic Details
Main Authors:	Naoki Matsumoto, Hiroto Abe, Ryohei Kawasaki, Yoshihito Tashiro, Mariko Noguchi-Sasaki, Suguru Harada, Koichiro Yoneyama, Tomomi Niino, Tetsuhiro Soeda, Yasushi Yoshimura
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2023-07-01
Series:	TH Open
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/a-2122-7887

Similar Items

Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab
by: Hannah Glonnegger, et al.
Published: (2022-08-01)

Emicizumab-induced photosensitivity
by: Pedro Asensi Cantó, et al.
Published: (2022-07-01)

BRAZILIAN REGISTRY OF PERSONS WITH HEMOPHILIA A RECEIVING EMICIZUMAB (EMICIZUMAB CASES, EMCASE PROJECT)
by: R.M. Camelo, et al.
Published: (2020-11-01)

Traumatic Tonsillar Hemorrhage during Hemophilia A Treatment with Emicizumab
by: Fumiya Inoue, et al.
Published: (2022-03-01)

Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro
by: Mariko Noguchi-Sasaki, et al.
Published: (2018-01-01)

Emicizumab in the treatment of hemophilia A
by: Tijanić Ivan R., et al.
Published: (2020-01-01)

Emicizumab Associated Rhabdomyolysis in Hemophilia A
by: Joseph A. Wilson, et al.
Published: (2020-10-01)

P1616: EMICIZUMAB FOR THE MANAGEMENT OF ACQUIRED HEMOPHILIA A
by: Meera Sridharan, et al.
Published: (2023-08-01)

Influence of emicizumab on protein C-mediated clotting regulation
by: Federica Mancazzo, et al.
Published: (2023-10-01)

Disruptive technology and hemophilia care: The multiple impacts of emicizumab
by: Cedric Hermans, et al.
Published: (2021-05-01)

Expert opinion paper on the treatment of hemophilia A with emicizumab
by: Francisco-José López-Jaime, et al.
Published: (2023-12-01)

Management of children with hemophilia A on emicizumab who need surgery
by: Mark Belletrutti, et al.
Published: (2023-04-01)

THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
by: Юлия Олеговна Рождественская, et al.
Published: (2023-02-01)

The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
by: Nina Haagenrud Schultz, et al.
Published: (2021-07-01)

TAXAS ANUALIZADAS DE SANGRAMENTO DURANTE O PRIMEIRO ANO DE PROFILAXIA COM EMICIZUMABE: RESULTADOS PRELIMINARES DO REGISTRO NACIONAL DE EMICIZUMABE (PROJETO EMCASE)
by: LCM Henriques, et al.
Published: (2023-10-01)

Management of Urgent Bleeding in Patients with Hemophilia A: Focus on the Use of Emicizumab
by: Víctor Jiménez-Yuste, et al.
Published: (2024-04-01)

Emicizumab for acquired hemophilia A: Report of two cases and dosing strategies
by: Faiza Ahmed, et al.
Published: (2024-04-01)

Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
by: Ricardo Mesquita Camelo, et al.
Published: (2023-12-01)

Kinetic analysis of ternary and binary binding modes of the bispecific antibody emicizumab
by: Stefanie Mak, et al.
Published: (2023-12-01)

Haemophilia A management with emicizumab: A survey of haematologists in the United States
by: Patel Anisha M., et al.
Published: (2022-03-01)

Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations
by: Yada K, et al.
Published: (2019-07-01)

Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
by: Brinza Melen, et al.
Published: (2024-01-01)

Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
by: Sarina Levy-Mendelovich, et al.
Published: (2021-09-01)

Cerebellar hematoma in severe hemophilia with inhibitor on emicizumab prophylaxis: a case report
by: Sami Albattat, et al.
Published: (2023-02-01)

Management of multiple myeloma in a patient with haemophilia with concurrent emicizumab – case report
by: Davies Elizabeth, et al.
Published: (2021-12-01)

Emicizumab in acquired haemophilia A: about two clinical cases and literature review
by: Amandine Hansenne, et al.
Published: (2021-08-01)

Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A
by: Kadhim Al-Banaa, et al.
Published: (2021-11-01)

PB2647: USE OF EMICIZUMAB FOR THE TREATMENT OF ACQUIRED HEMOPHILIA A: A SYSTEMATIC REVIEW
by: Zainab Al-Housni, et al.
Published: (2023-08-01)

A SIMULATION STUDY TO PROVIDE GUIDANCE FOR INDIVIDUALS TRANSITIONING FROM EMICIZUMAB TO VALOCTOCOGENE ROXAPARVOVEC
by: W Kuwabara, et al.
Published: (2023-10-01)

Absence of Effect of Emicizumab on D-Dimer Concentrations in Adult Patients with Severe Hemophilia A
by: Michael Iarossi MD, et al.
Published: (2022-12-01)

CHOLECYSTECTOMY IN A MAN WITH HEMOPHILIA A AND INHIBITOR ON EMICIZUMAB PROPHYLAXIS: A CASE REPORT
by: PC Giacometto, et al.
Published: (2021-10-01)

Emicizumab Prophylaxis in Patients with Severe Hemophilia A: Insights from A Resource Limited Country
by: Munira Borhany MD, et al.
Published: (2024-01-01)

RELATO DE CASO DE PACIENTE EM USO DE EMICIZUMABE – TRAJETÓRIA E AVANÇOS
by: JJS Pereira
Published: (2023-10-01)

RODA DE CONVERSA COM PACIENTES EM USO DE EMICIZUMABE: RELATO DE EXPERIÊNCIA
by: AOR Sacramento, et al.
Published: (2023-10-01)

Physical activity limitations in children with severe hemophilia A. does emicizumab make a difference?
by: Ahmed Sobhi Hassan, et al.
Published: (2023-05-01)

Quantification of emicizumab by mass spectrometry in plasma of people with hemophilia A: A method validation study
by: Anouk A. M. T. Donners, et al.
Published: (2022-05-01)

Prophylactic emicizumab for hemophilia A in the Asia‐Pacific region: A randomized study (HAVEN 5)
by: Renchi Yang, et al.
Published: (2022-02-01)

Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab
by: Pierre Fontana, et al.
Published: (2020-12-01)

Emicizumab in hemophilia A with inhibitors: clinical and economic impact of its use in a Cuban patient
by: Dunia Castillo-Gonzàles, et al.
Published: (2022-09-01)

Optimization and evaluation of a two-stage chromogenic assay procedure for measurement of emicizumab plasma levels.
by: Nasim Shahidi Hamedani, et al.
Published: (2022-01-01)